UK MHRA: MD Guidance - Register Medical Devices to Place on the Market
UK MHRA: Guidance on EC Decision Reliance Procedure Extended till 31 Dec, 2023 & Nitrosamine Risk
MHRA Guidance: Licensing of Biosimilar Products
UK MHRA: 150-Day Assessment for National Applications
UK MHRA Guidance: Register to Manufacture, Import or Distribute Act.Sub, & Reclassify Products
UK's MHRA Guidance: Software & AI as a Medical Device Change Programme
UK MHRA Guidance: How to get a Parallel Import Licence in UK
MHRA Guidance: Export Drugs & Medicine, Active substances Manufactured in GB for use in EEA & NI
UK MHRA: European Commission Decision Reliance Procedure (EC DRP) Extension
MHRA Guidance: Good Clinical Practice for Clinical Trials
UK MHRA Guidance: The Northern Ireland MHRA Authorised Route (NIMAR)